92.64
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$92.39
Offen:
$92.39
24-Stunden-Volumen:
1.13M
Relative Volume:
0.14
Marktkapitalisierung:
$118.48B
Einnahmen:
$36.36B
Nettoeinkommen (Verlust:
$4.84B
KGV:
24.86
EPS:
3.7261
Netto-Cashflow:
$5.43B
1W Leistung:
+0.61%
1M Leistung:
+6.41%
6M Leistung:
+1.54%
1J Leistung:
-1.41%
Medtronic Plc Stock (MDT) Company Profile
Firmenname
Medtronic Plc
Sektor
Branche
Telefon
01135314381700
Adresse
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT vs ABT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
MDT
Medtronic Plc
|
92.62 | 118.18B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
ABT
Abbott Laboratories
|
106.17 | 182.59B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
272.14 | 106.03B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
45.80 | 65.19B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.53 | 49.99B | 6.30B | 1.07B | 1.09B | 1.8406 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-13 | Fortgesetzt | Barclays | Overweight |
| 2026-02-09 | Hochstufung | Needham | Hold → Buy |
| 2026-02-03 | Fortgesetzt | Citigroup | Buy |
| 2026-01-30 | Fortgesetzt | Wells Fargo | Overweight |
| 2026-01-06 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2025-11-19 | Hochstufung | Goldman | Sell → Neutral |
| 2025-06-30 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2025-06-16 | Eingeleitet | Leerink Partners | Outperform |
| 2025-03-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-10-10 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | Bestätigt | Oppenheimer | Perform |
| 2024-08-15 | Hochstufung | UBS | Sell → Neutral |
| 2024-08-14 | Herabstufung | Stifel | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | Herabstufung | UBS | Buy → Sell |
| 2023-01-09 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-11-23 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-11-16 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-18 | Eingeleitet | Barclays | Equal Weight |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-08-24 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | Eingeleitet | Wolfe Research | Underperform |
| 2022-06-01 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | Herabstufung | Needham | Buy → Hold |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-01-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-06-10 | Fortgesetzt | Cowen | Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Equal Weight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-12-15 | Hochstufung | Goldman | Sell → Neutral |
| 2020-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | Hochstufung | Stifel | Hold → Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-05-14 | Herabstufung | DZ Bank | Buy → Hold |
| 2020-03-30 | Herabstufung | Needham | Strong Buy → Buy |
| 2020-03-25 | Hochstufung | DZ Bank | Hold → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Sell |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2020-01-02 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-06-05 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | Bestätigt | Needham | Strong Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2019-01-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-12-19 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-08-27 | Bestätigt | Argus | Buy |
Alle ansehen
Medtronic Plc Aktie (MDT) Neueste Nachrichten
Medtronic Raises 2027 Outlook as Broad-Based Growth Gains Momentum - Yahoo Finance
Hedeker Wealth LLC Sells 17,444 Shares of Medtronic PLC $MDT - MarketBeat
Beacon Investment Advisory Services Inc. Has $6 Million Position in Medtronic PLC $MDT - MarketBeat
HighTower Advisors LLC Has $30.77 Million Holdings in Medtronic PLC $MDT - MarketBeat
Medtronic stock heads into the open after a 1.9 percent drop - AD HOC NEWS
Medtronic Touts AI, Robotics and Ablation Growth at Wells Fargo Conference - MarketBeat
Medtronic (MDT) Q1 2027 Earnings Call - finance.biggo.com
Medtronic PLC stock outperforms competitors despite losses on the day - MarketWatch
Medtronic Diabetes at Wells Fargo conference: product wave drives growth - Investing.com India
Medtronic Diabetes at Wells Fargo conference: product wave drives growth By Investing.com - Investing.com UK
Medtronic plc stock gains as fiscal 2027 guidance raised after strong first quarter - AD HOC NEWS
Medtronic at Wells Fargo healthcare conference: growth broadens By Investing.com - Investing.com Canada
Medtronic at Wells Fargo healthcare conference: growth broadens - Investing.com
Is Medtronic Worth Buying as Growth Improves but Risks Stay Elevated? - The Globe and Mail
Teleflex Appoints Medtronic Veteran Sean Salmon to Board of Directors - citybiz.co
Teleflex appoints former Medtronic executive to board By Investing.com - Investing.com Canada
Medtronic (NYSE:MDT): A Dividend Quality Play for Income Investors - ChartMill
Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors - Stock Titan
Amundi Has $455.62 Million Stock Holdings in Medtronic PLC $MDT - MarketBeat
Medtronic (NYSE:MDT): Can Clinical Progress Outweigh Rate Pressures? - Kalkine Media
Medtronic executives to speak at upcoming investor conferences - marketscreener.com
Novocure Reports Patient Data Exposure in Cybersecurity Incident - Zacks Investment Research
Medtronic plc (MDT) Stock Analysis: Unpacking a Potential 11.25% Upside in the Medical Device Sector - DirectorsTalk Interviews
Medtronic PLC $MDT Holdings Raised by First Eagle Investment Management LLC - MarketBeat
Concurrent Investment Advisors LLC Decreases Stock Holdings in Medtronic PLC $MDT - MarketBeat
Azimuth Capital Investment Management LLC Sells 25,976 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic Plc Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Moomoo
Saudi Central Bank Has $7.03 Million Holdings in Medtronic PLC $MDT - MarketBeat
Medtronic plc stock gains on strong quarterly figures and guidance - AD HOC NEWS
Medtronic (NYSE:MDT) Flashes a High-Quality Breakout Setup - ChartMill
Oakmont Investment Advisors Inc. Takes $2.10 Million Position in Medtronic PLC $MDT - MarketBeat
NEOS Investment Management LLC Boosts Holdings in Medtronic PLC $MDT - MarketBeat
Continuum Advisory LLC Sells 44,102 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Purchased by AXQ Capital LP - MarketBeat
Two Medtronic executives will answer questions in live webcasts - Stock Titan
Renal Denervation Market Size, Share & Trends Analysis - GlobeNewswire Inc.
Medtronic (NYSE: MDT) Reports $9.76 Billion Revenue and $1.47 Billion Net Income for Q3 2026 - kalkinemedia.com
Medtronic plc stock gains as fiscal 2027 guidance is raised after strong first quarter - AD HOC NEWS
Daiwa Securities Adjusts Price Target on Medtronic to $108 From $95, Maintains Buy Rating - marketscreener.com
Medtronic PLC $MDT Shares Sold by Nwam LLC - MarketBeat
Allen Mooney & Barnes Investment Advisors LLC Lowers Holdings in Medtronic PLC $MDT - MarketBeat
Medtronic plc SEC Filing (Sep 3, 2026) - Stock Titan
Earnings rise at Medtronic (NYSE: MDT) after Q1 sales near $10 billion - Stock Titan
Medtronic plc 1Q 2026: Revenue $9.76B, EPS $1.14— 10-Q Summary - TradingView
Tranche Update on Medtronic plc's Equity Buyback Plan announced on June 23, 2017. - marketscreener.com
Medtronic invests $700M in surgical partner Cornerstone Robotics - therobotreport.com
Medtronic Announces Appointment of Masooma Sandeep as Head of Communications, TURMECA Region-led Markets - marketscreener.com
Medtronic expands investment ecosystem with $780M in new deals - BioWorld News
Bernstein raises Medtronic stock price target on solid results By Investing.com - Investing.com UK
Ablation Powers Medtronic’s Q1 As It Funnels Capital Into Robotics And Structural Heart - insights.citeline.com
JPMorgan Adjusts Price Target on Medtronic to $96 From $86, Maintains Neutral Rating - marketscreener.com
Finanzdaten der Medtronic Plc-Aktie (MDT)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):